A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Official Title: “A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients”

This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use.

Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.

Intervention(s) in this Clinical Trial

• Behavioral: nurse-delivered stage-matched smoking cessation counseling

Primary Measures

• Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokers
  • Time Frame: continuous abstinence for one month at the time of 3, 6 and 12 month follow up
    

Secondary Measures

• Reduction of the number of cigarettes smoked
  • Time Frame: at the time of 3, 6 and 12 month follow up
    
• Progression to a higher stage of readiness to quit
  • Time Frame: at the time of 3, 6 and 12 month follow up
    

Inclusion Criteria:

• Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization.
• Patient speaks and reads Cantonese/Chinese

Exclusion Criteria:

• Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention.
• Patient who does not speak or read Chinese

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Lead Investigator: Hospital Authority, Hong Kong Other

Overall Clinical Trial Officials and Contacts

Sophia SC Chan, Dr Principal Investigator Department of Nursing Studies, The University of Hong Kong  

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00563199

Study ID Number: NTWC/CREC/325/04

ClinicalTrials.gov Identifier: NCT00563199

Health Authority: Hong Kong: Ethics Committee